Effects of 3-phenylamino-1,2-propanediol and its mono- and dioleylesters on the production of reactive oxygen metabolites in human polymorphonuclear leukocytes

Toxicology Letters

Volumn 91, Issue 1, 1997, Pages 39-45

  Heiskanen, Kaisa M ^a,b   Savolainen, Kai M ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

3 Phenylamino 1,2 propanediol; Polymorphonuclear leukocytes; Reactive oxygen metabolites; Toxic oil syndrome

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROPANEDIOL DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST; TOXIC OIL SYNDROME;

ANALYSIS OF VARIANCE; CELL SEPARATION; CELL SURVIVAL; CHEMILUMINESCENT MEASUREMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTERS; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PROPYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; TETRADECANOYLPHORBOL ACETATE;

EID: 0031567103     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(96)03862-3     Document Type: Article

References (32)

1. [1] Tabuenca, J.M. (1981) Toxic-allergic syndrome caused by ingestion of rapeseed oil denaturated with aniline. Lancet ii, 567-568.
2. [2] Kilbourne, E.M., Bernert, J.T., Posada de la Paz, M., Hill, R.H., Abaitua Borda, I., Kilbourne, B.W., Zack, M.M. and the Toxico-Epidemiologic Study Group (1988) Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain. Am. J. Epidemiol. 127, 1210-1227.
3. [3] Posada de la Paz, M., Philen, R.M., Abaitua Borda, I., Bernert, J.T., Bada Gancedo, J.C., DuClos, P.J. and Kilbourne, E.M. (1991) Manufacturing processes at two French rape seed companies: possible relationships to toxic oil syndrome in Spain. Food Chem. Toxicol. 29, 797-803.
4. [4] Hill, R.H., Schúrz, H.H., Posada de la Paz, M., Abaitua Borda, I., Philen, R.M., Kilbourne, E.M., Head, S.L., Bailey, S.L., Driskell, W.J., Barr, J.R. and Needham, L.L. (1995) Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol. Arch. Environ. Contam. Toxicol. 28, 259-264.
5. [5] Kilbourne, E.M., Posada de la Paz, M., Abaitua Borda, I., Ruiz-Navarro, M.D., Philen, R.M. and Falk, H. (1991) Toxic Oil Syndrome: A current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome. J. Am. Coll. Cardiol. 18, 711-717.
6. [6] Garcia Gi, M., van Lookeren Campagne, M.W., Alemany, S., Municio, A.M. and Mato, J.M. (1983) Effect of fatty acid anilides on the generation of arachidonic acid by human polymorphonuclear leukocytes treated with linoleyl anilide. Biochem. Pharmacol. 33, 3303-3306.
7. [7] Khan, M.F., Kaphalia, B.S., Palafox, A., Jerrels, T.R. and Ansari, G.A.S. (1991) Toxicity of oleic acid anilides in rats. Arch. Environ. Contam. Toxicol. 21, 571-577.
8. [8] Kaufman, L.D., Izquierdo Martinez, M., Serrano, J.M. and Gomez-Reino, J.J. (1995) 12-year follow-up study of epidemic Spanish toxic oil syndrome. J. Rheumatol. 22, 282-288.
9. [9] Aldridge, W.N. (1992) The Toxic Oil Syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism. Toxicol. Lett. 64/65, 59-70.
10. [10] Bell, S.A., Hobbs, M.V. and Rubin, R.L. (1992) Isotype-restricted hyperimmunity in a murine model of the toxic oil syndrome. J. Immunol. 148, 3369-3376.
11. [11] Yoshida, S.H., German, J.B., Fletcher, M.P. and Gershwin, M.E, (1994) The toxic oil syndrome: a perspective on immunotoxicological mechanisms. Regul. Toxicol. Pharmacol. 19, 60-79.
12. [12] Gallardo, S., del Pozo, V., Cardaba, B., de Andres B., Martin-Orozco, E., Fernandez, J.C., Tramon, P., Posada, M., Abaitua, I., Palomino, P. and Lahoz, C. (1994) Immunological basis of toxic oil syndrome (TOS). Toxicology 93, 289-299.
13. [13] Bell, S.A., Du Clos, T.W., Khursigara, G., Picazo, J.J. and Rubin, R.L. (1995) Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in toxic oil syndrome. J. Autoimmun. 8, 293-303.
14. [14] Silver, R.M. (1992) Eosinophilia-myalgia syndrome, toxic oil syndrome, and diffuse fasciitis with eosinophilia. Curr. Opin. Rheumatol. 4, 851-856.
15. [15] Bolster, M.B. and Silver, R.M. (1994) Eosinophilia-myalgia syndrome, toxic oil syndrome, and diffuse fasciitis with eosinophilia. Curr. Opin. Rheumatol. 6, 642-649.
16. [16] Mayeno, A.N., Belongia, E.A., Lin, F., Lundy, S.K. and Gleich, G.J. (1992) 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin. Proc. 67, 1201-1201.
17. [17] Mayeno, A.N., Benson, L.M., Naylor, S., Colberg-Beers, M., Puchalski, J.T. and Gleich, G.J. (1995) Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia myalgia syndrome. Chem. Res. Toxicol. 8, 911-916.
18. [18] McCord, J.M. (1993) Oxygen-derived free radicals. New Horizons 1, 70-76.
19. [19] Hollan, S. (1995) Free radicals in health and disease. Haematologia 26, 177-189.
20. [20] Heiskanen, K., Ruotsalainen, M. and Savolainen, K. (1995) Interactions of cis-fatty acids and their anilides with formyl-Methionyl-Leucyl-Phenylalanine, phorbol myristate acetate and dioctanoyl-s,n-glycerol in human leukocytes. Toxicology 104, 115-121.
21. [21] Heiskanen, K.M. and Savolainen, K.M. (1996) Formyl-methionyl-leucyl-phenylalanine and a calcium ionophore A23187 reverse the inhibition of phorbol myristate acetate-induced oxidative burst by linoleic and oleic acid anilide, Toxicology 110, 39-45.
22. [22] Heiskanen, K.M. and Savolainen, K.M. (1996) Palmitic acid anilide-induced respiratory burst in human polymor-phonuclear leukocytes is inhibited by a protein kinase C inhibitor, Ro 31-8220. Free Radic. Biol. Med., in press.
23. [23] Heiskanen, K.M., Naarala, J. and Savolainen, K.M. (1995) The effects of N-(5-vinyl-1,3-thiazolidin-2-ylidene)phenylamine (5-VTPA) on the changes in free intracellular calcium and the production of reactive oxygen metabolites in human leukocytes. Toxicology 100, 195-200.
24. [24] Nakamura, S. and Nishizuka, Y. (1994) Lipid mediators and protein kinase C activation for the intracellular signaling network. J. Biochem. 115, 1029-1034.
25. [25] Segal, A.W. and Abo, A. (1993) The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18, 43-47.
26. [26] Böyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21, 77-89.
27. [27] Weening, R.S., Roos, D. and Loos, J.A. (1974) Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations. J. Lab. Clin. Med. 83, 570-576.
28. [28] Dechatelet, L.R., Long, G.D., Shirley, P.S., Bass, D.A., Thomas, M.J., Henderson, F.W. and Cohen, M.S. (1982) Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J. Immunol. 129, 1589-1593.
29. [29] Tuomala, M., Hirvonen, M,-R. and Savolainen, K.M. (1993) Changes in free intracellular calcium and the production of reactive oxygen metabolites in human leukocytes by soluble and particulate stimuli. Toxicology 80, 71-82.
30. [30] Maestro Duran, R., Ruiz Gutiérrez, V. and Roncero, A. (1986) Toxic oil syndrome in Spain: Toxicological study in mice of new aniline derivatives present in toxic oils. Erasas y aceites 37, 207-214.
31. [31] Carthew, P., Edwards, R.E., Dorman, B.M. and Verschoyle, R.D. (1995) A comparison of the pathology induced by 3-phenylamino-1,2-propanediol (PAP) and its mono-oleyl ester in rodents with the toxic oil syndrome in man. Hum. Exp. Toxicol. 14, 217-220.
32. [32] Umei, T., Ohhara, N., Okamura, S., Harada, M., Nakao, M., Shirai, T. and Niho, Y. (1993) Activation of neutrophils NADPH oxidase by PMA: cytosol activity is translocated in phorbol-primed neutrophils. Int. J. Biochem. 25, 631-633.